Brief: Shenzhen Neptunus Interlong Bio-Technique Expects Net Profit Attributable To Owners Of RMB 7 Million For 2026 Interim Period
12/08/2026 09:45
BRIEF-Shenzhen Neptunus Interlong Bio-Technique Expects Net Profit Attributable To Owners Of RMB 7 Million For 2026 Interim Period Aug 12 (Reuters) - Shenzhen Neptunus Interlong Bio-technique Co Ltd 8329.HK:
EXPECTS NET PROFIT ATTRIBUTABLE TO OWNERS OF RMB7 MILLION FOR 2026 INTERIM PERIOD
REVENUE DECREASED ABOUT 12% FOR 2026 INTERIM PERIOD
Further company coverage: 8329.HK
((reuters.briefs@thomsonreuters.com))
Recent news on Shenzhen Neptunus Interlong Bio-technique
See all newsBrief: Shenzhen Neptunus Interlong Bio-Technique's Unit Enters Into JV Agreement With Huikang Bio-Technology
China's Neptunus Interlong H1 revenue falls
Brief: Shenzhen Neptunus Interlong Bio-Technique Expects Net Profit Attributable To Owners Of RMB 7 Million For 2026 Interim Period
Brief: Shenzhen Neptunus Interlong Bio-Technique Posts FY Loss & Total Comprehensive Expenses Attributable RMB40.7 Million
Brief: Shenzhen Neptunus Interlong Bio-Technique Sees FY Net Loss Attributable Of RMB40 Million